Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

March 25, 2024

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

January 19, 2024

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

News Daily News

Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry

October 16, 2023

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

News Daily News

FDA Approves Blood Flow-Diverting LimFlow System for No-Option CLTI

September 12, 2023

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

March 29, 2023

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

News Daily News

REVIVE Injects Fresh Data Into Surgery vs Stenting Controversy for PAD

January 24, 2023

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

June 29, 2020

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

News Daily News

Endo-First Strategy Matches Surgery in Select CLI Patients: Retrospective Data

July 30, 2019

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

January 10, 2019

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

December 18, 2018

News Daily News

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

January 20, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.